Payments to Acquire Property, Plant, and Equipment of INTEGRATED BIOPHARMA INC from 30 Sep 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
INTEGRATED BIOPHARMA INC quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 30 Sep 2010 to 30 Sep 2025.
  • INTEGRATED BIOPHARMA INC Payments to Acquire Property, Plant, and Equipment for the quarter ending 30 Sep 2025 was $173,000, a 209% increase year-over-year.
  • INTEGRATED BIOPHARMA INC annual Payments to Acquire Property, Plant, and Equipment for 2025 was $191,000, a 65% decline from 2024.
  • INTEGRATED BIOPHARMA INC annual Payments to Acquire Property, Plant, and Equipment for 2024 was $553,000, a 377% increase from 2023.
  • INTEGRATED BIOPHARMA INC annual Payments to Acquire Property, Plant, and Equipment for 2023 was $116,000, a 76% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $173,000 +$117,000 +209% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2026 Q1
Q3 2024 $56,000 +$18,000 +47% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2026 Q1
Q3 2023 $38,000 -$12,000 -24% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2025 Q1
Q3 2022 $50,000 -$81,000 -62% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2024 Q1
Q3 2021 $131,000 +$78,000 +147% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2023 Q1
Q3 2020 $53,000 -$5,000 -8.6% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q1
Q3 2019 $58,000 +$40,000 +222% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2021 Q1
Q3 2018 $18,000 -$89,000 -83% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2020 Q1
Q3 2017 $107,000 +$66,000 +161% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2019 Q1
Q3 2016 $41,000 $0 0% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q3 2015 $41,000 -$127,000 -76% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2017 Q1
Q3 2014 $168,000 +$166,000 +8300% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2016 Q1
Q3 2013 $2,000 -$6,000 -75% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2015 Q1
Q3 2012 $8,000 +$7,000 +700% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2014 Q1
Q3 2011 $1,000 -$144,000 -99% 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012 2013 Q1
Q3 2010 $145,000 01 Jul 2010 30 Sep 2010 10-Q 21 Nov 2011 2012 Q1

INTEGRATED BIOPHARMA INC Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $191,000 -$362,000 -65% 01 Jul 2024 30 Jun 2025 10-K 23 Sep 2025 2025 FY
2024 $553,000 +$437,000 +377% 01 Jul 2023 30 Jun 2024 10-K 23 Sep 2025 2025 FY
2023 $116,000 -$370,000 -76% 01 Jul 2022 30 Jun 2023 10-K 20 Sep 2024 2024 FY
2022 $486,000 +$191,000 +65% 01 Jul 2021 30 Jun 2022 10-K 15 Sep 2023 2023 FY
2021 $295,000 +$81,000 +38% 01 Jul 2020 30 Jun 2021 10-K 13 Sep 2022 2022 FY
2020 $214,000 -$200,000 -48% 01 Jul 2019 30 Jun 2020 10-K 02 Sep 2021 2021 FY
2019 $414,000 +$167,000 +68% 01 Jul 2018 30 Jun 2019 10-K 23 Sep 2020 2020 FY
2018 $247,000 -$80,000 -24% 01 Jul 2017 30 Jun 2018 10-K 29 Aug 2019 2019 FY
2017 $327,000 +$218,000 +200% 01 Jul 2016 30 Jun 2017 10-K 12 Sep 2018 2018 FY
2016 $109,000 -$126,000 -54% 01 Jul 2015 30 Jun 2016 10-K 01 Sep 2017 2017 FY
2015 $235,000 +$53,000 +29% 01 Jul 2014 30 Jun 2015 10-K 02 Sep 2016 2016 FY
2014 $182,000 +$152,000 +507% 01 Jul 2013 30 Jun 2014 10-K 04 Sep 2015 2015 FY
2013 $30,000 -$125,000 -81% 01 Jul 2012 30 Jun 2013 10-K 08 Sep 2014 2014 FY
2012 $155,000 -$146,000 -49% 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2013 2013 FY
2011 $301,000 01 Jul 2010 30 Jun 2011 10-K 15 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.